Pagina 4 - I migliori medici di Screening oncologico - TOP-106medici

La dottoressa Severine Iborra è il capo del reparto di ginecologia e ostetricia presso il Städtisches Klinikum Solingen. Le sue responsabilità comprendono l'ostetricia, la sala parto, il reparto neonatale e la ginecologia. Il reparto include anche la clinica di senologia/mammologia presso il Bergisches Breast Center Solingen, diretta dalla dottoressa Manuela Seifert.

La dottoressa Severine Iborra è originaria della Francia. Ha iniziato a studiare medicina presso l'Università di Lione e poi si è trasferita all'Università Albert-Ludwig di Friburgo, dove ha ottenuto la licenza medica nel 2007. Nel 2008 ha conseguito il dottorato per ricerche sperimentali nel campo dell'oncologia molecolare. Da agosto 2008 a novembre 2013, la dottoressa Iborra ha lavorato come residente presso la Clinica Universitaria delle Donne di Friburgo. Dopo aver superato gli esami di specializzazione in ginecologia e ostetricia, ha continuato la sua carriera come specialista nella stessa clinica. Nel novembre 2015 si è trasferita alla clinica universitaria RWTH ad Aquisgrana come maggior medico.

Presso la Clinica di Ginecologia e Ostetricia sotto la direzione del professor dottor E. Stickeler, la dottoressa Iborra ha diretto il reparto ostetrico dal 2017 al 2019. Da dicembre 2017 si è occupata dell'organizzazione della formazione nel reparto e nell'ottobre 2019 è diventata medico capo amministrativo e medico capo del personale della clinica, mantenendo questa posizione fino al trasferimento a Solingen.

Oltre al suo lavoro scientifico, con numerose pubblicazioni e presentazioni a grandi conferenze ginecologiche, la dottoressa Iborra ha approfondito le sue specializzazioni mediche. Ha ottenuto certificazioni in diagnostica e terapia oncologica dal Gynecological Oncology Working Group e ulteriori qualifiche in patologia del collo dell'utero e colposcopia (AGCPC), uroginecologia e chirurgia ricostruttiva pelvica (AGUP) e dall'Associazione Professionale dei Ginecologi (BVF).

Nel 2019 la dottoressa Iborra ha completato con successo una specializzazione aggiuntiva in "oncologia ginecologica" e "ostetricia speciale e medicina perinatale". È membro attivo delle principali società mediche tedesche nel suo campo, tra cui la Società tedesca di ginecologia e ostetricia, il Gruppo di lavoro per la patologia del collo dell'utero e colposcopia e la Società tedesca di medicina prenatale e del parto.

Procedure offerte nel nostro reparto di ginecologia

• Isteroscopia, oltre a dilatazione e raschiamento (D&C) a scopo diagnostico e terapeutico.
• Rimozione di formazioni ovariche anomale o sintomatiche, come cisti, con preservazione dell'ovaio residuo.
• Ovariectomia (rimozione delle ovaie) in caso di anomalie o a scopo preventivo su indicazione.
• Miomectomia (rimozione di miomi uterini) con conservazione dell'utero.
• Trattamento conservativo del fibroma: farmacologico o embolizzazione effettuata da specialisti in radiologia.
• Isterectomia con o senza rimozione del collo dell'utero.
• Diagnosi e chiarimento di dati poco chiari nell'area del collo dell'utero, della vagina e della vulva.
• Trattamento della displasia.
• Trattamento dell'endometriosi.
• Trattamento del cancro alla vulva, alla vagina, al collo dell'utero, all'utero e alle ovaie.
• Trattamento dell'incontinenza urinaria e/o del prolasso degli organi pelvici.

Quando possibile, offriamo tutte le procedure come trattamenti minimamente invasivi utilizzando la laparoscopia o il sistema robotico Da Vinci.

Lee Ji Hyun, MD, — chirurgo della mammella e della tiroide. Lee Ji Hyun è a capo del reparto di chirurgia della mammella e della tiroide presso il Naeun Hospital. Profilo clinico: malattie benigne della mammella, carcinoma della mammella, oncochirurgia. Inoltre: malattie benigne della tiroide, carcinoma della tiroide, patologia delle paratiroidi. Competenze: procedure Mammotome, interventi sui linfonodi ascellari, ecografie della mammella e della tiroide.

Istruzione e formazione: College di Medicina dell'Università Yonsei. Tirocinio e residenza in chirurgia generale presso l'ospedale Severance dell'Università Yonsei. Breve stage clinico presso un ospedale affiliato all'Istituto di ricerca sul cancro in Giappone.

Principali posizioni: capo del reparto di chirurgia generale presso l'Incheon Christian Hospital e specialista in chirurgia generale al Cheil Hospital. Direttore del Centro della mammella e capo del reparto di chirurgia presso il Samsung Cheil Hospital. Capo del reparto di chirurgia generale e vicedirettore del servizio clinico presso il Cheil Hospital. Professore a contratto di chirurgia al CHA Gangnam Medical Center, Università CHA. Capo del reparto di chirurgia generale presso il Daejeong Hospital.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.

Dr. Son Dong Wan, MD, PhD, is the Chief of Urology at Naeun Hospital. He specializes in urologic oncology, urinary incontinence, sexual dysfunction, and laser prostate surgery. He performs robotic and laparoscopic surgery for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction (UPJ) obstruction.

He earned his PhD from Pusan National University. He completed his internship and residency at Pusan National University Hospital. He is a former Chief at Wallace Memorial Baptist Hospital. He served as a Professor at the Catholic University College of Medicine. He was a Clinical Fellow at Seoul National University Bundang Hospital. He was a Visiting Professor at the University of California, San Diego (UCSD). He completed training in urinary incontinence surgery at the University of Liège.

Awards include the Excellent Paper Award (2007) and the Academic Achievement Award (2014) from the Korean Continence Society. He also received the Best Poster Award from the European Association of Urology (2013).

Dr. Michael Lotem leads the Melanoma and Cancer Immunotherapy Center at Hadassah Medical Center. He specializes in advanced immunotherapy for melanoma. He is known for his research on SLAM receptors and their role in anti-cancer immune responses. Dr. Lotem has published widely in leading medical journals.

He heads a multidisciplinary team that uses clinical data and patient samples to advance research. Under his leadership, the center has improved patient outcomes with new therapies. The center is now recognized as a leader in cancer immunotherapy.

Dr. Zuhal Cakmak Peksen is a Family Medicine Specialist since 2017. She earned her MD from Çukurova University in 2010. She completed specialty training at Yüzüncü Yıl University between 2013 and 2017. She is currently studying for a bachelor’s degree in Health Management at Anadolu University (2024–present).

She has 15 years of clinical practice (2010–2025) across 8 institutions. Her experience includes research in Family Medicine (2013–2017) and work at several Family Health Centers. Since 2020, she has served at TOKİ Avrupa Family Health Center in Gaziosmanpaşa, Istanbul.

2017: Oticon Medical Scientific Center Copenhagen Denmark.
2016: ICLO Teaching Center New Endoscopic Approaches to Lateral Skull Base, Inner Ear and Cerebello-Pontine Angle, Verona Italy
2016: World Hearing Center, Institute of Physiology and Pathology of Hearing, Warsaw,Poland
2015: Cochlear Science and Research Center Berlin Germany.
2014: Cochlear implant Center Medel Company Innsburck, Austria.
2014: Hannover Medical School. Clinic for Laryngology, Rhinology and Otology, Hannover, Germany
2014: Academy of Hearing Aid Acoustics (Akademie für Hörgerate-Akustik), Lübeck, Germany.
2013: International European Sialendoscopy Training Center, Geneva, Switzerland.
2012: University clinic of ORL, Head and Neck Surgery, klinikum der Universitat, Munchen, Germany.
2012: University clinic of ORL, Head and Neck Surgery, Bern, Switzerland.
2011: University clinic of ORL, Head and Neck Surgery, klinikum der Universitat, Munchen, Germany.
2007: The Ohio State University, Medical Faculty, Department of Otolaryngology, Division of Otology and Neurotology. Columbus, Ohio, USA.
2006: University of Würzburg, Department of Otolaryngology, Division of Otology and Neurotology. Würzburg, Germany.
1999-2003 İnönü Üniversitesi Tıp Fakültesi Kulak Burun Boğaz Anabilim Dalı
1993-1999 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi

Turkish Otorhinolaryngology and Head and Neck Surgery Association

Turkish Otorhinolaryngology and Head and Neck Surgery Foundation

Turkish Rhinology Society

Tigris-Euphrates Basin Otorhinolaryngology and Head and Neck Surgery Association

Gaziantep Otorhinolaryngology Association

Turkish Otorhinolaryngology and Head and Neck Surgery Qualification Board

Turkish Otology Association

Malatya Otorhinolaryngology Association

American Academy of Otolaryngology Head and Neck Surgery

Mediterranean Society of Otology and Audiology

International Vertigo Association

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Il Dottor Tamonwan Trongpanyachot (Dottor Bi) è un medico presso la clinica Plenary Wellness a Phuket. Specializzato in medicina estetica, anti-aging e rigenerativa. Ha completato gli studi presso l'Università Medica di Lublino (Polonia).

Esperto in procedure estetiche moderne: botox, filler dermici, Sculptra e biostimolatori. Si pone l'obiettivo di ottenere risultati naturali e duraturi. Nella medicina rigenerativa, esegue terapie PRP per capelli, mesoterapia dei capelli con PRP e cellule staminali per il ringiovanimento della pelle.

Collabora con l'Università del Principe di Songkla (Phuket) per sostenere la ricerca e l'innovazione nel campo del benessere. Parla correntemente il tailandese, l'inglese e il cinese.